CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.53B, above the global median of $1.2B
- FinancialsAltman Z-Score 2.43: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.65%Below 5Y avg (1.03%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
33.0%Sustainable
Last Ex-Dividend
Apr 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.28BCNY1.53B · vs all stocks (USD)
Trailing P/E
51.96xRevenue (TTM)
2.67BCNY397.86M · vs all stocks (USD)
Profit Margin
7.53%Beta
-0.1180xvs all stocks
52-Week Change
-19.13%vs all stocks
Market Capitalization
10.28BCNY1.53B · vs all stocks (USD)
Enterprise Value
11.65BCNY1.74B · vs all stocks (USD)
Trailing P/E
51.96xForward P/E
23.98xPrice to Sales (TTM)
3.86xPrice to Book (MRQ)
2.34xEnterprise to Revenue
4.37xEnterprise to EBITDA
20.95xGross Margin
52.99%Profit Margin
7.53%Operating Margin
15.92%Return on Assets (TTM)
2.59%Return on Equity (TTM)
3.10%Revenue (TTM)
2.67BCNY397.86M · vs all stocks (USD)
Revenue per Share (TTM)
3.24CNYUpdated Sep 19, 2026Quarterly Revenue Growth
-2.00%Gross Profit (TTM)
1.43BCNY213.35M · vs all stocks (USD)
EBITDA (TTM)
343.51MCNY51.26M · vs all stocks (USD)
Net Income (TTM)
200.72MCNY29.95M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-5.70%Operating Cash Flow (TTM)
374.53MCNY55.89M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
59.28MCNY8.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0806CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
0.65%vs all stocks
5-Year Average Dividend Yield
1.03%vs all stocks
Payout Ratio
33.04%Minority Interest (Equity)
1.11BCNYFY2025 · Dec 31, 2025Revenue
2.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.34BCNYFY2025 · Dec 31, 2025Gross Profit
1.40BCNYFY2025 · Dec 31, 2025Operating Income
390.48MCNY58.27M · vs all stocks (USD)
Pre-tax Income
211.44MCNYFY2025 · Dec 31, 2025Income Tax Expense
57.00MCNYFY2025 · Dec 31, 2025Net Income
154.44MCNYFY2025 · Dec 31, 2025EBIT
348.98MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
561.82MCNYFY2025 · Dec 31, 2025Research & Development
232.61MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
432.52MCNYFY2025 · Dec 31, 2025Other Operating Expenses
53.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.17MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
137.54MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
154.44MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
41.19MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
339.86MCNYFY2025 · Dec 31, 2025Free Cash Flow
-20.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
844.73MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
154.44MCNYFY2025 · Dec 31, 2025Other Non-cash Items
162.14MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-53.99MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
77.28MCNYFY2025 · Dec 31, 2025Capital Expenditures
-360.28MCNYFY2025 · Dec 31, 2025Net Acquisitions
-115.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-1.35BCNYFY2025 · Dec 31, 2025Sale of Investments
1.15BCNYFY2025 · Dec 31, 2025Other Investing Activity
1.03MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-554.67MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
486.97MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-704.91MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-110.37MCNYFY2025 · Dec 31, 2025Other Financing Charges
414.62MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
86.32MCNYFY2025 · Dec 31, 2025Shares Outstanding
824.60MSharesUpdated Sep 19, 2026Float Shares
470.12MSharesUpdated Sep 19, 2026% Held by Insiders
43.40%vs all stocks
% Held by Institutions
4.60%vs all stocks
Total Cash (MRQ)
884.41MCNY131.97M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.07CNYUpdated Sep 19, 2026Total Debt (MRQ)
1.32BCNY196.35M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2468xCurrent Ratio (MRQ)
1.45xBook Value per Share (MRQ)
5.33CNYUpdated Sep 19, 2026Total Assets
9.22BCNY1.38B · vs all stocks (USD)
Total Current Assets
2.68BCNYFY2025 · Dec 31, 2025Total Liabilities
3.76BCNYFY2025 · Dec 31, 2025Total Non-current Assets
6.54BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.12BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.64BCNYFY2025 · Dec 31, 2025Cash
847.08MCNYFY2025 · Dec 31, 2025Cash Equivalents
23.67MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
870.75MCNYFY2025 · Dec 31, 2025Other Short-term Investments
225.22MCNYFY2025 · Dec 31, 2025Accounts Receivable
963.96MCNYFY2025 · Dec 31, 2025Inventory
532.57MCNYFY2025 · Dec 31, 2025Accounts Payable
583.93MCNYFY2025 · Dec 31, 2025Short-term Debt
317.86MCNYFY2025 · Dec 31, 2025Other Current Liabilities
13.70MCNYFY2025 · Dec 31, 2025Long-term Debt
437.74MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.22MCNYFY2025 · Dec 31, 2025Common Stock (Book)
824.60MCNYFY2025 · Dec 31, 2025Retained Earnings
1.50BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.46BCNY815.29M · vs all stocks (USD)
52-Week Low
12.05CNYUpdated Sep 19, 202652-Week High
16.14CNYUpdated Sep 19, 202652-Week Change
-19.13%vs all stocks
Beta
-0.1180xvs all stocks
50-Day MA
12.86CNYUpdated Sep 19, 2026200-Day MA
13.22CNYUpdated Sep 19, 2026Avg 10-Day Volume
4.92MSharesUpdated Sep 19, 2026Avg 30-Day Volume
6.95MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
0.2400CNYUpdated Sep 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.53Profit Margin: 0.08
Financial Health
Altman Z-Score 2.43: grey zoneSignificant
Altman Z-Score: 2.43
High earnings qualityNotable
Earnings Quality Score: 1.40
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.53B, above the global median of $1.2BNotable
Market cap (USD): 1,534,385,753.566Global Median: 1,201,862,193
Companies that share the same coordination system — how they create, deliver, or capture value.
Taysha Gene Therapies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Idorsia Ltd
Tier 1ProductionApproval-Gated PipelineRuleRisk
Alphatec Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Anhui Hongyu Wuzhou Medica Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Balance Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tyra Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sihuan Pharmaceutical Holdings Group Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BeBetter Med Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk